Submitted by Anonymous (not verified) on 20 August 2024 - 10:26
Human medicines European public assessment report (EPAR): Imlygic, talimogene laherparepvec, Date of authorisation: 16/12/2015, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imlygic, talimogene laherparepvec, Date of authorisation: 16/12/2015, Revision: 14, Status: Authorised